Streamline Health Solutions (STRM) AI Stock Analysis

• Market Cap: $22.56M
• Dividend Yield: N/A
• Average Volume (3M): 139.78K
• Price to Earnings (P/E): ―
• Beta (1Y): 2.21
• Revenue Growth: -14.88%
• EPS Growth: 54.76%
• Country: US
• Employees: 70
• Sector: Healthcare
• Sector Strength: 42
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.40
• Shares Outstanding: 4,356,062
• 10 Day Avg. Volume: 32,527
• 30 Day Avg. Volume: 139,778
• PEG Ratio: -0.19
• Price to Book (P/B): 1.93
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -10.53
• Enterprise Value/Market Cap: 1.56
• Enterprise Value/Revenue: 0.47
• Enterprise Value/Gross Profit: 3.95
• Enterprise Value/Ebitda: -1.64
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 51 Neutral
• Price Target: $5.00 ▼(-3.47%Downside)

The overall score reflects a challenging financial situation with negative profitability and cash flow issues. Despite these, the stock's strong technical indicators and the positive impact of a significant merger announcement provide some upside potential.

Streamline Health Solutions Business Overview & Revenue Model

Company Description

Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions, professional consulting, and auditing and coding services, which capture, aggregate, and translate structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which include an integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a coding analysis platform, as well as software services. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; Cerner Command Language (CCL) reporting; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

How the Company Makes Money

Streamline Health Solutions generates revenue through the sale and subscription of its software solutions, which are primarily targeted at healthcare providers looking to enhance their revenue cycle processes. The company charges licensing fees for its software products and also earns recurring revenue through subscription-based services, which may include software updates, technical support, and additional features. Furthermore, Streamline Health Solutions engages in professional services for implementation, training, and consulting, which constitute another revenue stream. Partnerships with other healthcare technology firms and entities may also play a role in expanding their market reach and enhancing their product offerings.

Streamline Health Solutions Financial Statement Overview

Summary

Streamline Health Solutions is facing significant financial challenges with declining revenues and persistent losses, leading to negative margins and cash flow issues. High leverage and negative equity returns further compromise financial stability.

Income Statement

Streamline Health Solutions has faced declining revenues over the years, from $24.89M in 2023 to $18.38M TTM, indicating a negative revenue growth trajectory. The gross profit margin improved slightly to 48.3% TTM, but net income remains negative, leading to a negative net profit margin of -49.3% TTM. The EBIT and EBITDA margins are also negative, highlighting ongoing operational challenges.

Balance Sheet

The company has a high debt-to-equity ratio of 1.26 TTM, indicating significant leverage. Stockholders' equity has decreased, weakening the equity ratio to 30.9% TTM. Although the return on equity is negative due to persistent net losses, the reduction in total assets and liabilities suggests some efforts to manage financial structure, albeit with limited success.

Cash Flow

Operating cash flow is negative at -$1.28M TTM, and free cash flow remains negative at -$2.14M TTM, indicating cash management issues. The free cash flow to net income ratio is below 1, reflecting insufficient cash generation relative to net losses. There is no significant improvement in free cash flow growth, pointing to ongoing cash flow constraints.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	18.38M	17.90M	22.60M	24.89M	17.38M	11.35M
Gross Profit	8.88M	8.34M	11.54M	11.49M	8.80M	5.66M
EBITDA	-2.20M	-3.29M	-12.82M	-6.25M	-2.93M	-4.80M
Net Income	-9.06M	-10.16M	-18.70M	-11.38M	-6.92M	-4.80M
Balance Sheet
Total Assets	35.83M	35.58M	41.73M	61.52M	61.81M	25.98M
Cash, Cash Equivalents and Short-Term Investments	1.45M	2.18M	3.19M	6.60M	9.88M	2.41M
Total Debt	13.98M	13.12M	10.57M	9.75M	10.14M	2.72M
Total Liabilities	24.77M	23.30M	22.92M	26.01M	27.77M	8.49M
Stockholders Equity	11.05M	12.28M	18.81M	35.51M	34.04M	17.49M
Cash Flow
Free Cash Flow	-2.14M	-2.37M	-3.84M	-9.08M	-5.00M	-7.58M
Operating Cash Flow	-1.28M	-1.51M	-2.21M	-7.14M	-3.50M	-5.76M
Investing Cash Flow	-858.00K	-858.00K	-1.62M	-1.94M	-13.17M	9.46M
Financing Cash Flow	-388.00K	1.36M	428.00K	5.79M	24.15M	-2.94M

Streamline Health Solutions Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5.18
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For STRM, the sentiment is Positive. The current price of 5.18 is above the 20-day moving average (MA) of 5.18, above the 50-day MA of 3.66, and above the 200-day MA of 3.29, indicating a bullish trend. The MACD of 0.45 indicates Positive momentum. The RSI at 80.37 is Negative, neither overbought nor oversold. The STOCH value of 71.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for STRM.

Streamline Health Solutions Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	59 Neutral	£5.89B	9.26	-57.69%	4.66%	14.66%	-8.59%
STRM	51 Neutral	$22.56M	―	-63.93%	―	-14.88%	54.76%
PRPH	46 Neutral	$15.25M	―	-58.71%	―	-79.66%	-141.87%
BCDA	44 Neutral	$11.13M	―	-737.89%	―	-99.36%	63.06%
CTXR	38 Underperform	$17.10M	―	-60.06%	―	―	8.99%
LPTX	31 Underperform	$10.84M	―	-202.81%	―	―	64.01%
MOVE	23 Underperform	$4.87M	―	-439.23%	―	―	56.73%

Streamline Health Solutions Corporate Events

Streamline Health Solutions Announces Merger with MDaudit

Streamline Health Solutions reported a 12% increase in total revenue for the fiscal first quarter of 2025, reaching $4.8 million, primarily due to new SaaS contracts, despite some client non-renewals. The company also announced a definitive merger agreement with MDaudit, set to acquire Streamline in a $37.4 million all-cash transaction, expected to close in the third quarter of 2025, offering a significant premium to shareholders.

Streamline Health Solutions Announces Merger with MDaudit

On May 29, 2025, Streamline Health Solutions entered into a merger agreement with MDaudit, under which MDaudit will acquire all outstanding shares of Streamline for $5.34 per share in cash, representing a 138% premium over Streamline’s closing price on May 28, 2025. This merger aims to combine Streamline’s pre-bill integrity solutions with MDaudit’s billing compliance and revenue integrity platform, enhancing the ability to unify data silos and drive coordinated actions across the revenue cycle continuum, ultimately improving financial stability for healthcare organizations.

The most recent analyst rating on (STRM) stock is a Buy with a $22.50 price target. To see the full list of analyst forecasts on Streamline Health Solutions stock, see the STRM Stock Forecast page.